SoftServe Named as a Major Contender in Healthcare Payer Digital Services by Everest Group
12.7.2022 14:05:00 EEST | Business Wire | Press release
SoftServe, a leading digital authority and consulting company, has been named a Major Contender by Everest Group's Healthcare Payer Digital Services PEAK Matrix® Assessment 2022. The recognition marks the first year that SoftServe has participated in Everest Group's annual healthcare payer digital services marketplace assessment.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220712005092/en/
SoftServe a Major Contender in Healthcare Payer Digital Services PEAK Matrix Assessment 2022 (Graphic: Business Wire)
"Being named as a Major Contender in Everest Group's PEAK Matrix for Healthcare Payer Digital Services acknowledges SoftServe's significant digital healthcare experience," said Adam Gabrault, President, Strategic Verticals & Industry Solutions, North America at SoftServe. "It demonstrates how we accelerate outcomes across the healthcare continuum by providing our clients with innovative solutions and deep domain expertise."
Everest Group's Healthcare Payer Digital Services PEAK Matrix Assessment analyzes the relative market impact and overall capabilities of 26 service and technology providers. The report focuses on market size and growth, digital service themes for healthcare payers, and assessments of capabilities and market success-related dimensions. In addition, Everest Group offers independent remarks on these service providers.
SoftServe was recognized as a Major Contender by demonstrating its next-generation healthcare services delivery capabilities with the company's Human360® Member Digital Experience Platform. The member-centric solution enhances data aggregation, engagement, and care management. Everest Group highlighted SoftServe's ability to leverage its strategic partner ecosystem to augment and manage data. The report also notes SoftServe's positive client feedback on price flexibility, technical expertise, and client management.
"Business themes such as payer-provider collaboration, interoperability, value-based care, and member experience are driving the demand for digital adoption among payers,” said Chunky Satija, Vice President at Everest Group. “Along with its strategic focus of enhancing its digital capabilities through COEs and a strong partner ecosystem, SoftServe is also augmenting its vertical capabilities by building healthcare native IPs, such as DataMask solution and Member Digital Experience platform, to drive value for clients. SoftServe’s strong technical expertise and delivery excellence coupled with its focus on providing innovative price constructs has enabled it to be positioned as a Major Contender in Healthcare Payer Digital Services PEAK Matrix® Assessment 2022."
View an extract of the Healthcare Payer Digital Services PEAK Matrix Assessment 2022 here.
About SoftServe
SoftServe is a digital authority that advises and provides at the cutting-edge of technology. We reveal, transform, accelerate, and optimize how enterprises and software companies do business. Our end-to-end solutions and expertise deliver innovation, quality, and speed across the healthcare, retail, energy, manufacturing, and financial services verticals. We empower enterprises and software companies to (re)identify differentiation, accelerate solution development, and vigorously compete in today’s marketplace—no matter where you are in your journey.
Visit our website, blog, LinkedIn, Facebook, and Twitter.
For additional background on the work SoftServe has done to be named a Major Contender in the healthcare payer digital services marketplace, please come to our Healthcare & Life Sciences page.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220712005092/en/
Contact information
Andrew Kavka
Analyst and Public Relations Lead
akavk@softserveinc.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Lenovo Unveils Adaptive AI PCs, Modular Concepts, and Lenovo Qira Rollout at MWC 20262.3.2026 01:01:00 EET | Press release
At MWC® 2026, Lenovo™ introduces a new generation of adaptive AI devices and forward-looking concepts designed for business professionals, creators, students, and gamers. Headlined by new modular PC architecture, a glasses-free 3D laptop concept, a foldable gaming handheld device, and the initial rollout of Lenovo Qira, Lenovo’s showcase reflects a broader shift in personal computing toward systems that adapt intelligently to people and their environments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260301217460/en/ Across its portfolio, Lenovo continues to focus on delivering technology that is more personalized, proactive, and protected, while building a unified AI ecosystem that works naturally across devices. “The AI era will not be defined by a single device or application, but by intelligent systems that work seamlessly across everything we use,” said Luca Rossi, President, Intelligent Devices Group, Lenovo. “We are
TVCMALL MWC 2026 -tapahtumassa: johtava mobiilitarvikkeiden tukkukauppa ja älykäs hankinta1.3.2026 08:00:00 EET | Tiedote
MWC Barcelona 2026 korostaa tekoälyn, yhteyksien ja älykkäämpien teknologisten järjestelmien kasvavaa merkitystä, ja samalla mobiilitarvikemarkkinat siirtyvät uuteen vaiheeseen, jota leimaavat nopeus ja monimutkaisuus. Tuotekategoriat laajenevat jatkuvasti, muotoilut ja tyylit päivittyvät yhä nopeammin, ja jälleenmyyjiltä odotetaan reagointia markkinamuutoksiin entistä lyhyemmissä sykleissä. Tuotevalikoiman ajantasaisena pitäminen samalla kun hankintaa hallitaan tehokkaasti on muodostunut todelliseksi haasteeksi jälleenmyyjille ja jakelijoille eri puolilla Eurooppaa. Tämä lehdistötiedote sisältää multimediaa. Katso koko julkaisu täällä: https://www.businesswire.com/news/home/20260121785166/fi/ TVCMALL MWC 2026 -tapahtumassa: johtava mobiilitarvikkeiden tukkukauppa ja älykäs hankinta MWC Barcelona 2026 - Tapahtumassa TVCMALL korostaa rooliaan Euroopan johtavana yhden luukun puhelin tarvikkeita tukkutoimittajana, keskittyen selkeästi siihen, että tukkukauppa ja hankinta olisivat helpompi
TVCMALL at MWC 2026: Leading Mobile Accessories Wholesale and Smarter Sourcing1.3.2026 08:00:00 EET | Press release
As MWC Barcelona 2026 highlights the growing role of AI, connectivity, and smarter technology systems, the mobile accessories market is entering a new phase defined by speed and complexity. Product categories continue to expand, designs and styles update faster, and retailers are expected to respond to market changes in shorter cycles. Keeping product lines up to date while managing sourcing efficiently has become a real challenge for retailers and distributors across Europe. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260121405485/en/ TVCMALL at MWC 2026: Leading Mobile Accessories Wholesale and Smarter Sourcing At MWC Barcelona 2026, TVCMALL highlights its role as a leading one-stop mobile accessories wholesaler in Europe, with a clear focus on making wholesale and sourcing easier, faster, and more reliable. With more than 18 years of experience, TVCMALL works closely with 30+ leading retail partners across Europe, supp
Biocytogen Announces Clinical Milestone with First Patient Dosed in Phase 1 Trial of IDEAYA’s First-in-Class B7H3/PTK7 Bispecific TOP1 ADC IDE03428.2.2026 02:00:00 EET | Press release
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315), a global biotechnology company that drives the research and development of novel antibody-based drugs with innovative technologies, today announced that its partner IDEAYA Biosciences, Inc. (“IDEAYA”; Nasdaq: IDYA) has dosed the first patient in IDEAYA’s Phase 1 dose-escalation/expansion clinical trial of IDE034, an investigational B7H3/PTK7 bispecific TOP1 ADC. Pursuant to the companies’ option and license agreement, first patient dosing triggers a $5 million milestone payment to Biocytogen. According to IDEAYA, the Phase 1 study is designed to characterize IDE034’s safety profile, tolerability, and PK as a monotherapy, and IDEAYA also intends to evaluate combination regimens with DNA damage response (DDR) -targeting agents such as its oral PARG inhibitor IDE161 as the program advances. IDE034 is a potential first-in-class bispecific B7H3/PTK7 TOP1 ADC, independently developed by Biocytogen and lice
IQM and Real Asset Acquisition Corp. to Host Conference Call/Webcast to Discuss Proposed Transaction27.2.2026 14:00:00 EET | Press release
IQM Finland Oy, a global leader in full-stack superconducting quantum computers (“IQM”, “IQM Quantum Computers” or the “Company”), and Real Asset Acquisition Corp. (Nasdaq: RAAQ), a special purpose acquisition company (“RAAQ”), announced that they will host a conference call to discuss their recently announced business combination, including certain transaction highlights. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260227472716/en/ IQM Radiance quantum computer As previously disclosed, on February 23, 2026, IQM and RAAQ announced they have entered into a definitive business combination agreement, which will result in IQM becoming a public company and listing American Depositary Shares on one of the two leading U.S. stock exchanges. The transaction provides funding with the aim to accelerate IQM’s technology and commercial development towards fault-tolerance quantum computing, further advancing its position as a leading p
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom